Shopping Cart
- Remove All
- Your shopping cart is currently empty
Uprosertib hydrochloride is a potent and selective inhibitor of pan-Akt (IC50: 180/328/38 nM for Akt1/Akt2/Akt3, respectively).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,720 | 1-2 weeks | |
50 mg | $3,580 | 1-2 weeks | |
100 mg | $4,900 | 1-2 weeks |
Description | Uprosertib hydrochloride is a potent and selective inhibitor of pan-Akt (IC50: 180/328/38 nM for Akt1/Akt2/Akt3, respectively). |
Targets&IC50 | ROCK1:1570 nM, ROCK2:1850 nM, CDK7:2100 nM, Akt3:38 nM, Akt1:180 nM, Akt2:328 nM |
In vitro | Protein targets that bind Uprosertib in the lysate display a dose-dependent reduction in binding to the kinobeads, while proteins unaffected by the drug display no reduction in binding. Uprosertib inhibits Akt1/2/3 (Kd: 16/49/5 nM, respectively) and it also potently inhibits only the PKC family members PRKACA and PRKACB as well as the cGMP-dependent protein kinase PRKG1 aqpart from the Akts[1]. |
Alias | GSK2141795 (hydrochloride) |
Molecular Weight | 465.71 |
Formula | C18H17Cl3F2N4O2 |
Cas No. | 1047635-80-2 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.